KIDABION Trademark

Trademark Overview

On Monday, September 4, 2006, a trademark application was filed for KIDABION with the United States Patent and Trademark Office. The USPTO has given the KIDABION trademark a serial number of 79028734. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, February 1, 2015. This trademark is owned by Merck KGaA. The KIDABION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of deficiencies of the immune system, deficiencies in metabolic functions and concentration deficiencies; dietetic foods adapted for medical use on the basis of vitamins, minerals, trace elements, amino acids, herbal and marine substances, enzymes, plant and fish oils and fats, cultured bacteria preparations and substances, bee products, fiber; pharmaceutical preparations consisting of combinations of the aforesaid for use in the treatment of deficiencies of the immune system, deficiencies in metabolic functions and concentration deficiencies; pharmaceutical preparations in the nature of tonics for use in the treatment of general states of exhaustion
kidabion

General Information

Serial Number79028734
Word MarkKIDABION
Filing DateMonday, September 4, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, February 1, 2015
Registration Number3335471
Registration DateTuesday, November 13, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 28, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of deficiencies of the immune system, deficiencies in metabolic functions and concentration deficiencies; dietetic foods adapted for medical use on the basis of vitamins, minerals, trace elements, amino acids, herbal and marine substances, enzymes, plant and fish oils and fats, cultured bacteria preparations and substances, bee products, fiber; pharmaceutical preparations consisting of combinations of the aforesaid for use in the treatment of deficiencies of the immune system, deficiencies in metabolic functions and concentration deficiencies; pharmaceutical preparations in the nature of tonics for use in the treatment of general states of exhaustion

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 20, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Consumer Healthcare Limited
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressGB
Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, August 14, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, August 14, 2015DEATH OF INTERNATIONAL REGISTRATION
Friday, July 17, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Monday, June 29, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, June 29, 2015INVALIDATION PROCESSED
Friday, February 20, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 20, 2014CANCELLED SECTION 71
Saturday, May 4, 2013NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 30, 2010CHANGE OF OWNER RECEIVED FROM IB
Monday, June 21, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 21, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 4, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 15, 2008FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 15, 2008FINAL DISPOSITION PROCESSED
Wednesday, February 13, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 13, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, August 28, 2007PUBLISHED FOR OPPOSITION
Wednesday, August 8, 2007NOTICE OF PUBLICATION
Friday, July 20, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 16, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 12, 2007AMENDMENT FROM APPLICANT ENTERED
Thursday, July 5, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 5, 2007PAPER RECEIVED
Tuesday, June 5, 2007FINAL REFUSAL E-MAILED
Tuesday, June 5, 2007FINAL REFUSAL WRITTEN
Monday, June 4, 2007AMENDMENT FROM APPLICANT ENTERED
Wednesday, May 16, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 4, 2007ASSIGNED TO LIE
Wednesday, May 16, 2007PAPER RECEIVED
Wednesday, May 16, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 16, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 1, 2006REFUSAL PROCESSED BY IB
Thursday, November 16, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 16, 2006REFUSAL PROCESSED BY MPU
Thursday, November 16, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 15, 2006NON-FINAL ACTION WRITTEN
Tuesday, November 14, 2006ASSIGNED TO EXAMINER
Friday, October 20, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, October 19, 2006SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

kidabion deficiencies preparations pharmaceutical treatment substances concentration functions immune system metabolic